Skip to main content
Clinical Trials/NCT03161899
NCT03161899
Completed
Not Applicable

Evaluation of Nutritional Status in Patients With Thalassemia Major in Assiut University Children Hospital

Assiut University1 site in 1 country246 target enrollmentDecember 15, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Thalassemia Major
Sponsor
Assiut University
Enrollment
246
Locations
1
Primary Endpoint
percentage of malnutrition
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Thalassemia is a blood disorder passed down through families in which the body makes an abnormal form of hemoglobin. There are 2 main types of thalassemia; Alpha & Beta thalassemia. Alpha thalassemia: occurs when a gene or genes related to the alpha globin protein are missing or mutated.

Beta-thalassemia syndromes are a group of hereditary blood disorders characterized by reduced or absent beta globin chain synthesis. Beta-thalassemias can be classified into:

Silent carrier: completely asymptomatic with normal hematological parameters. Beta-thalassaemia minor (beta-thalassaemia trait): usually asymptomatic; diagnosis is made during a work-up for mild anemia.

Beta-thalassaemia intermedia: usually a similar presentation to beta-thalassaemia major; symptoms are usually less pronounced and the course is usually more insidious.

Beta-thalassaemia major : In which there is complete absence of hemoglobin A

Detailed Description

In Egypt beta thalassemia-major is the most common type with carrier rate of 5.3 to ≥9%and 1000 new cases born with beta-thalassemia major per 1.5 million live births per year. Children born with thalassemia major are normal at birth, but develop severe hemolytic anemia during the first year of life. Symptoms are those of anemia (lethargy, poor feeding, pallor...etc.) failure to thrive and organomegaly. Later on they develop signs of extra medullary hematopoiesis . Optimal nutritional status is important for growth, immune function, bone health and pubertal development . Various reports suggest the incidence of poor growth ranges from 25% to 75% depending on thalassemia syndrome and severity of disease. This marked growth deficits raise a red flag for any pediatrician to evaluate nutritional status of thalassemic patients and detect possible nutritional deficiencies and associated factors. Etiology of delayed growth and malnutrition reported in thalassemic patient is multifactorial including : 1. Nutritional deprivation with or without feeding difficulties arising from fatigue and breathlessness 2. Increased energy expenditure secondary to hyper metabolism with or without heart failure 3. Gastrointestinal hypoxia which consequently produces anorexia and malabsorption 4. Reduction of biosynthetic activity of liver. 5. Disturbance of the endocrine function 6. Impaired synthetic hepatic function secondary to hemosiderosis and hepatitis. The main aim of this study is to assess the nutritional status of thalassemic patient attending Assiut university Children hospital and to determine the factors involved.

Registry
clinicaltrials.gov
Start Date
December 15, 2018
End Date
July 20, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

ARAbdelmonem

resident doctor of pediatrics

Assiut University

Eligibility Criteria

Inclusion Criteria

  • patients diagnosed to have thalassemia

Exclusion Criteria

  • patient with any underlaying systemic diseases other than B thalassemia major.

Outcomes

Primary Outcomes

percentage of malnutrition

Time Frame: 12 month

prevalence of malnutrition among thalassemic children attending assiut university children hospital

Secondary Outcomes

  • aetiology poor growth(12 month)
  • decrease morbidity(18 month)

Study Sites (1)

Loading locations...

Similar Trials